CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2
$4,000,066N01FY2022AINIH
Duke University, Durham NC
Investigators
Abstract
To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge vaccine platforms and approaches.
View original record on NIH RePORTER →